Ariad Pharmaceuticals Inc fka ARIA

[DewDiligence]

Merrill's 70% expectation after 57 days seems a little extreme after the Phase I results. Would you agree?

I don’t know enough detail to make an educated comment on McMinn’s expectation about the Ponatinib response rate; however, I think the heavy criticism on this board of McMinn’s expectation for “pristine results” is misplaced.

I can’t recall seeing a post on this board expressing an opinion about the expected rate of SAE’s in the PACE trial, so the complaining about McMinn strikes me as the message-board equivalent of post-hoc data mining.